Atlantic Medical

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Depression2 trials
• Type 2 diabetes2 trials
• COPD1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Osteoarthritis1 trial

Phase

• Phase 37 trials
• Phase 21 trial

Status

• Recruiting4 trials
• Active, not recruiting2 trials
• Not yet recruiting2 trials

Lead sponsor

• Eli Lilly and Company8 trials

Running trials

• Not yet recruiting

  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Phase 3· Eli Lilly and Company· Source

  Contact: Alex Dewdney (principal investigator)

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· Phase 3· Eli Lilly and Company· Source

  Contact: John Ryan (principal investigator)

• Recruiting

  A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  NCT07759245· Phase 2· Eli Lilly and Company· Source

  Contact: Tom Graver (principal investigator)

• Recruiting

  A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  NCT07412756· Phase 3· Eli Lilly and Company· Source

  Contact: John Ryan (principal investigator)

• Recruiting

  Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  NCT07353931· Phase 3· Eli Lilly and Company· Source

  Contact: Alex Dewdney (principal investigator)

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight

  NCT07232719· Phase 3· Eli Lilly and Company· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

  Contact: Alex Dewdney (principal investigator)

• Active, not recruiting

  A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity

  NCT06859268· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression2 recruiting
• Obesity2 recruiting
• COPD1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Osteoarthritis1 recruiting
• Type 2 diabetes1 recruiting